Literature DB >> 10431241

Mutations in the human homologue of mouse dl cause autosomal recessive and dominant hypohidrotic ectodermal dysplasia.

A W Monreal1, B M Ferguson, D J Headon, S L Street, P A Overbeek, J Zonana.   

Abstract

X-linked hypohidrotic ectodermal dysplasia results in abnormal morphogenesis of teeth, hair and eccrine sweat glands. The gene (ED1) responsible for the disorder has been identified, as well as the analogous X-linked gene (Ta) in the mouse. Autosomal recessive disorders, phenotypically indistinguishable from the X-linked forms, exist in humans and at two separate loci (crinkled, cr, and downless, dl) in mice. Dominant disorders, possibly allelic to the recessive loci, are seen in both species (ED3, Dlslk). A candidate gene has recently been identified at the dl locus that is mutated in both dl and Dlslk mutant alleles. We isolated and characterized its human DL homologue, and identified mutations in three families displaying recessive inheritance and two with dominant inheritance. The disorder does not map to the candidate gene locus in all autosomal recessive families, implying the existence of at least one additional human locus. The putative protein is predicted to have a single transmembrane domain, and shows similarity to two separate domains of the tumour necrosis factor receptor (TNFR) family.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10431241     DOI: 10.1038/11937

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  74 in total

Review 1.  Covering the limb--formation of the integument.

Authors:  Carolyn Byrne; Matthew Hardman; Kerry Nield
Journal:  J Anat       Date:  2003-01       Impact factor: 2.610

2.  Finding NEMO: genetic disorders of NF-[kappa]B activation.

Authors:  Jordan S Orange; Raif S Geha
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

Review 3.  The mammary bud as a skin appendage: unique and shared aspects of development.

Authors:  Marja L Mikkola; Sarah E Millar
Journal:  J Mammary Gland Biol Neoplasia       Date:  2006-10       Impact factor: 2.673

Review 4.  Biological tooth replacement.

Authors:  Rachel Sartaj; Paul Sharpe
Journal:  J Anat       Date:  2006-10       Impact factor: 2.610

5.  The Ectodysplasin receptor EDAR acts as a tumor suppressor in melanoma by conditionally inducing cell death.

Authors:  Jonathan Vial; Amélie Royet; Philippe Cassier; Antonin Tortereau; Sarah Dinvaut; Denis Maillet; Lise Gratadou-Hupon; Marion Creveaux; Alexa Sadier; Garance Tondeur; Sophie Léon; Lauriane Depaepe; Sophie Pantalacci; Arnaud de la Fouchardière; Olivier Micheau; Stéphane Dalle; Vincent Laudet; Patrick Mehlen; Marie Castets
Journal:  Cell Death Differ       Date:  2018-05-31       Impact factor: 15.828

6.  Attenuation of Mammary Gland Dysplasia and Feeding Difficulties in Tabby Mice by Fetal Therapy.

Authors:  Mandy Wahlbuhl; Sonia Schuepbach-Mallepell; Christine Kowalczyk-Quintas; Angela Dick; Fabian B Fahlbusch; Pascal Schneider; Holm Schneider
Journal:  J Mammary Gland Biol Neoplasia       Date:  2018-06-01       Impact factor: 2.673

7.  Mapping of a novel autosomal recessive hypotrichosis locus on chromosome 10q11.23–22.3.

Authors:  Gul Naz; Ghazanfar Ali; Syed Kamran-ul-Hassan Naqvi; Zahid Azeem; Wasim Ahmad
Journal:  Hum Genet       Date:  2010-04       Impact factor: 4.132

Review 8.  Mammary gland development.

Authors:  Hector Macias; Lindsay Hinck
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2012 Jul-Aug       Impact factor: 5.814

9.  Functional analysis of Ectodysplasin-A mutations causing selective tooth agenesis.

Authors:  Gabriele Mues; Aubry Tardivel; Laure Willen; Hitesh Kapadia; Robyn Seaman; Sylvia Frazier-Bowers; Pascal Schneider; Rena N D'Souza
Journal:  Eur J Hum Genet       Date:  2010-01       Impact factor: 4.246

10.  Enhanced Edar signalling has pleiotropic effects on craniofacial and cutaneous glands.

Authors:  Shie Hong Chang; Stephanie Jobling; Keith Brennan; Denis J Headon
Journal:  PLoS One       Date:  2009-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.